News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.

Just-Evotec Takes J.Train Continuous Platform to Market
Just-Evotec has launched its J.Train continuous biomanufacturing platform to the broader market following validation through a facility sale to Sandoz. The platform integrates end-to-end continuous

Achieve Life Sciences names new CEO, looks to raise $354 million
Achieve Life Sciences has appointed Andrew Goldberg as CEO while securing up to $354 million in funding to support its smoking cessation treatment and operations.

Washington’s life sciences jobs continue increasing, up 50% from 2014-2024: report
Washington’s life sciences employment grew 50% from 2014 to 2024, continuing to expand even as national job numbers declined slightly. The state added jobs year

From the ‘scurfy’ mouse to the Nobel Prize: How a Seattle biotech pioneer’s long game paid off
Seattle scientist Fred Ramsdell’s decades-long research into regulatory T cells culminated in a Nobel Prize and continues to shape new cell therapies. Ramsdell’s work began

Seattle Is America’s Next AI Capital. It Just Hasn’t Acted Like It Yet.
A new analysis argues that Seattle is uniquely positioned to lead the next decade of artificial intelligence development due to its infrastructure, talent, and cross-industry

Your Scale, Your Terms: How Modular Bioreactors Are Redefining Capacity & Manufacturing Strategies
AGC Biologics is advancing modular single-use bioreactor systems that enable a scale-out manufacturing approach to expand production capacity while maintaining consistent conditions. Instead of increasing

When Cancer Changes Identity
A new study co-led by the Institute for Systems Biology (ISB) shows that a rare form of lung cancer can change identity as it grows,

“Computational crystal ball” helps predict cell behavior
A new study presents a computational modeling system that enables scientists to predict how cells behave and change over time using an intuitive, language-based framework.

Why Nobel Prize winner David Baker remains committed to Seattle
University of Washington biochemist and Nobel Prize winner David Baker said he remains committed to staying in Seattle so he can focus on the work

Omeros rises as Novo deal boosts Q4 earnings
Omeros reported stronger-than-expected fourth quarter results, driven primarily by its partnership with Novo Nordisk for rare disease therapy zaltenibart. The company posted $86.5 million in

Immusoft Awarded $15 Million in Funding from the California Institute for Regenerative Medicine
Immusoft received a $15 million grant from the California Institute for Regenerative Medicine to support clinical development of its engineered B cell therapy, ISP-001, for

HSSA Awards $3.25 Million in Spokane County’s Bioscience and Health Industry
The Health Sciences and Services Authority (HSSA) of Spokane awarded $3.25 million in grants to five bioscience and health companies to support research, development, and
